influx. The distribution of P2X (P2X1-7) and P2Y (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11) receptors was different between lung cancer cells and normal cells. Proapoptotic P2X7 was nearly undetectable in lung cancer cells, which may explain why lung cancer cells showed decreased cytotoxicity when treated with high concentration of ATP. The Bcl-2/Bax ratio was increased in lung cancer cells following treatment with ATP; however, the antiapoptotic protein Bcl-2 demonstrated more sensitivity to ATP than proapoptotic protein Bax. Decreasing extracellular Ca 2ϩ or chelating intracellular Ca 2ϩ with BAPTA-AM significantly inhibited ATP-induced increase in Bcl-2/ Bax ratio, indicating that a rise in [Ca 2ϩ ]cyt through Ca 2ϩ influx is the critical mediator for ATP-mediated increase in Bcl-2/Bax ratio. Therefore, despite high ATP levels in the tumor microenvironment, which would induce cell apoptosis in normal cells, the decreased P2X7 and elevated Bcl-2/Bax ratio in lung cancer cells may enable tumor cells to survive. Increasing the Bcl-2/Bax ratio by exposure to high extracellular ATP may, therefore, be an important selective pressure promoting transformation and cancer progression. purinergic receptor; calcium signaling; Bcl-2; Bax; cell apoptosis; cell proliferation THERE IS GROWING INTEREST in the role of ATP in the development of cancer. ATP, well known as an intracellular molecular energy source, also functions as an extracellular messenger (2). ATP receptors are purinergic receptors (P2 receptors) and include the ligand-gated ion channel family of P2 receptors (P2X1-7) as well as the G protein-coupled receptor (GPCR) family of P2 receptors (P2Y1-2, P2Y 4 , P2Y 6 and P2Y11-14) (3, 31). Activation of P2X receptors, which are nonselective cation channels formed by three homomeric or heteromeric P2X subunits, directly results in Na ϩ and Ca 2ϩ influx through the cell plasma membrane, leading to membrane depolarization, which in turn activates voltage-gated Na ϩ and Ca 2ϩ channels and causes the firing of action potentials. Activation of P2Y receptors, which are GPCRs, increases cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) by inducing Ca 2ϩ release from intracellular stores (e.g., sarcoplasmic or endoplasmic reticulum) and Ca 2ϩ influx through store-operated (SOC) and/or receptor-operated (ROC) Ca 2ϩ channels. P2X and P2Y signaling is not only responsible for inducing action potentials in excitable cells (e.g., neurons), but also has been implicated in cell proliferation, differentiation, and apoptosis in nonexcitable cells (e.g., epithelial cells) (5). In a lung cancer cell line, A549, extracellular ATP, UTP, and UDP have been shown to stimulate proliferation that is dependent on the P2Y 2 and P2Y 6 receptors (44).
eliminated the plateau phase increase of [Ca 2ϩ ]cyt in lung cancer cells, indicating that the plateau phase of [Ca 2ϩ ]cyt increase is due to Ca 2ϩ influx. The distribution of P2X (P2X1-7) and P2Y (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11) receptors was different between lung cancer cells and normal cells. Proapoptotic P2X7 was nearly undetectable in lung cancer cells, which may explain why lung cancer cells showed decreased cytotoxicity when treated with high concentration of ATP. The Bcl-2/Bax ratio was increased in lung cancer cells following treatment with ATP; however, the antiapoptotic protein Bcl-2 demonstrated more sensitivity to ATP than proapoptotic protein Bax. Decreasing extracellular Ca 2ϩ or chelating intracellular Ca 2ϩ with BAPTA-AM significantly inhibited ATP-induced increase in Bcl-2/ Bax ratio, indicating that a rise in [Ca 2ϩ ]cyt through Ca 2ϩ influx is the critical mediator for ATP-mediated increase in Bcl-2/Bax ratio. Therefore, despite high ATP levels in the tumor microenvironment, which would induce cell apoptosis in normal cells, the decreased P2X7 and elevated Bcl-2/Bax ratio in lung cancer cells may enable tumor cells to survive. Increasing the Bcl-2/Bax ratio by exposure to high extracellular ATP may, therefore, be an important selective pressure promoting transformation and cancer progression. purinergic receptor; calcium signaling; Bcl-2; Bax; cell apoptosis; cell proliferation THERE IS GROWING INTEREST in the role of ATP in the development of cancer. ATP, well known as an intracellular molecular energy source, also functions as an extracellular messenger (2) . ATP receptors are purinergic receptors (P2 receptors) and include the ligand-gated ion channel family of P2 receptors (P2X1-7) as well as the G protein-coupled receptor (GPCR) family of P2 receptors (P2Y1-2, P2Y 4 , P2Y 6 and P2Y11-14) (3, 31) . Activation of P2X receptors, which are nonselective cation channels formed by three homomeric or heteromeric P2X subunits, directly results in Na ϩ and Ca 2ϩ influx through the cell plasma membrane, leading to membrane depolarization, which in turn activates voltage-gated Na ϩ and Ca 2ϩ channels and causes the firing of action potentials. Activation of P2Y receptors, which are GPCRs, increases cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) by inducing Ca 2ϩ release from intracellular stores (e.g., sarcoplasmic or endoplasmic reticulum) and Ca 2ϩ influx through store-operated (SOC) and/or receptor-operated (ROC) Ca 2ϩ channels. P2X and P2Y signaling is not only responsible for inducing action potentials in excitable cells (e.g., neurons), but also has been implicated in cell proliferation, differentiation, and apoptosis in nonexcitable cells (e.g., epithelial cells) (5) . In a lung cancer cell line, A549, extracellular ATP, UTP, and UDP have been shown to stimulate proliferation that is dependent on the P2Y 2 and P2Y 6 receptors (44) .
Extracellular or intercellular ATP concentration is reported to be very low (1-5 M) in normal healthy tissues; however, it is significantly increased (to Ͼ100 M) in the tumor microenvironment (26) . The effect of increased extracellular ATP on cancer cell function is, however, dependent of the expression of different P2 receptors and changes in cytosolic [Ca 2ϩ ] cyt due to activation of the different P2 receptors. Recent observations imply that differential expression of P2X and P2Y receptors may determine the kinetically distinct patterns of ATP-mediated increases in [Ca 2ϩ ] cyt ; the different patterns of Ca 2ϩ signaling may lead to differential effects on cancer cells (e.g., proliferation vs. apoptosis) (34) . This underscores the necessity of further characterization of P2 receptors in tumor cells, which could lead to novel therapeutic strategies that target purinergic signaling in the treatment of cancer.
Intracellular Ca 2ϩ plays a critical role in the regulation of processes relevant to tumorigenesis, including cell proliferation, migration, and apoptosis (1, 22, 34 transporters (22, 30) . For example, it has been shown that P2Y 2 and P2Y 4 receptor expression in A549 cells promotes an increase in [Ca 2ϩ ] cyt and induces Ca 2ϩ -dependent release of ATP and UTP as part of a positive feedback loop (4) .
The Bcl-2 protein family consists of both antiapoptotic and proapoptotic members, which are traditionally considered to reside in or translocate to mitochondria and function as apoptotic regulators by modulating mitochondrial membrane permeability. The ratio between anti-and proapoptotic Bcl-2 proteins determines whether cells survive or die (13) . The Bcl-2 family of proteins has also been detected in other subcellular compartments including the endoplasmic reticulum, nuclear membrane, plasma membrane and within the cytosol. Furthermore, the Bcl-2 family of proteins has been implicated in regulating [Ca 2ϩ ] homeostasis in these cellular compartments (15, 28, 41) , while changes in [Ca 2ϩ ] cyt also exert effects on the expression of the anti-or proapoptotic Bcl-2 proteins. The Bcl-2 family of proteins also functions to relay Ca 2ϩ signals to regulate cell apoptosis and proliferation. We hypothesize that there is a feedback loop in which Ca 2ϩ signaling regulates the expression of Bcl-2 family members, resulting in an increase of the Bcl-2/Bax ratio.
In this report, we show that extracellular ATP induces only a transient increase in [Ca 2ϩ ] cyt in normal lung epithelial cells; however, ATP induces a transient increase in [Ca 2ϩ ] cyt followed by a plateau phase (or a slowly declining phase) increase of [Ca 2ϩ ] cyt in lung cancer cells (H23 and A549) that is dependent on extracellular Ca 2ϩ . Furthermore, extracellular treatment with ATP increases the ratio of the antiapoptotic protein, Bcl-2, to the proapoptotic protein, Bax (Bcl-2/Bax ratio) in lung cancer cells, but not in normal lung epithelial cells. We also demonstrate that chelation of intracellular Ca 2ϩ (with BAPTA-AM) or removal of extracellular Ca 2ϩ inhibits the ATP-induced increase of Bcl-2/Bax ratio in lung cancer cells. These data imply that extracellular ATP, by selectively inducing a sustained or long-lasting increase in [Ca 2ϩ ] cyt in lung cancer cells (but not in normal lung epithelial cells), promotes cell survival and enhances lung tumor growth through increase of the Bcl-2/Bax ratio. Inhibiting ATP-induced Ca 2ϩ influx in lung cancer cells may lead to novel therapeutic approaches for lung cancer.
MATERIALS AND METHODS

Chemicals and drugs.
Adenosine 5-triphosphate disodium salt hydrate (ATP), uridine 5-triphosphate trisodium salt hydrate (UTP), ␣,␤-methylene adenosine 5-triphosphate lithium salt (␣,␤-meATP), ␤,␥-methyleneadenosine 5-triphosphate disodium salt (␤,␥-meATP), and TNP-ATP hydrate were prepared as concentrated stock solutions in distilled water. U-73122 hydrate, BAPTA-AM, and cyclopiazonic acid (CPA) were prepared as concentrated stock solutions in dimethyl sulfoxide (DMSO). All stock solutions (in water, DMSO) were aliquoted and kept frozen at Ϫ20°C until use. On the day of experiments, aliquots of the stock solutions were diluted in HEPES-buffered bath solution to the final concentrations for each drug. The pH values of all solutions were measured after addition of the drugs and adjusted to 7.4. All drugs were from Sigma Chemical, unless otherwise indicated.
Cell culture. Human non-small cell lung cancer cell lines A549 and H23 and human airway epithelial cell line BEAS-2B (American Type Culture Collection, Manassas, VA) were cultured in DMEM medium (Corning Cellgro, NY) supplemented with 10% fetal bovine serum (FBS, Invitrogen, Grand Island, NY), 100 IU/ml penicillin and 100 g/ml streptomycin (Sigma-Aldrich, St. Louis, MO). Cells were routinely cultured in 20% O 2 and 5% CO2 at 37°C.
Measurement of [Ca 2ϩ ]cyt. Human non-small cell lung cancer cell lines A549 and H23 and human airway epithelial cell line were grown at 50%-60% confluence on 25-mm diameter circular glass coverslips. Cells were loaded for 60 min in room temperature (23°C) with 4 M fura-2 acetoxymethyl ester (fura-2/AM; Invitrogen/Molecular Probes, Eugene, OR) in HEPES-buffered solution. Coverslips with cells were placed into the recording chamber of an inverted fluorescent microscope (Eclipse Ti-E; Nikon, Tokyo, Japan) equipped with an objective lens (S Plan Fluor ϫ20/0.45 ELWD; Nikon), an EM-CC camera (Evolve; Photometrics, Tucson, AZ) and the NIS Elements 3.2 software (Nikon), and superfused with HEPES-buffered solution for 30 min to wash out residual extracellular fura-2/AM and allow sufficient time for intracellular esterase to convert fura-2/AM to fura-2. With excitation at 340 and 380 nm, the emitted fluorescence was acquired at 520 nm by a fluorescent objective lens and an EM-CCD camera using NIS Elements 3.2 software. Intracellular Ca 2ϩ concentration was expressed as 340/380 fluorescence ratio within an area of interest in a cell recorded every 2 s. The HEPES-buffered solution contained (in mM) 137 NaCl, 5.9 KCl, 1.8 CaCl2, 1.2 MgCl2, 14 glucose, and 10 HEPES (pH was adjusted to 7.4 with 10 N NaOH). The Ca 2ϩ -free solution was prepared by replacing 1.8 mM CaCl 2 with equimolar MgCl 2 and adding 1 mM EGTA to chelate residual Ca 2ϩ . Measurement of [Ca 2ϩ ]cyt was carried out at room temperature (23°C). For each experimental replicate we quantitated the fluorescence ratios for at least 20 cells.
Western blotting. Total protein was isolated from human non-small cell lung cancer cell lines A549 and H23 and human airway epithelial cell lines that were lysed in 1ϫ RIPA buffer (Bio-Rad, Hercules, CA) at 4°C. Protein was loaded on a 15% acrylamide gel, transferred to an Immobilon-P transfer membrane (Millipore, Bedford, MA), and immunoblotted with anti-Bcl-2 and (SAB4500003; 1:1,000; SigmaAldrich) and anti-Bax monoclonal antibody (B3428; 1:4,000; SigmaAldrich). Signals were detected using a Super Signal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA). The protein levels were normalized to ␤-actin (sc-9104, 1:1,000; Santa Cruz Biotechnology) and are expressed in arbitrary units.
RT-PCR and real-time RT-PCR. Total RNA was isolated from human non-small cell lung cancer cell line A549 and H23 and human airway epithelial cell line by the TRIzol method. The extracted RNA was quantified by spectrophotometry at 260 nm. The synthesis and polymerase chain reaction were carried out using a Platinum PCR SuperMix (Invitrogen, Grand Island, NY) with 3-step cycling. The relative expression levels of P2X and P2Y receptors were normalized against the amount of GAPDH mRNA in the same RNA extract. Quantitative real-time RT-PCR was performed on a Bio-Rad iQ5 real-time PCR detection system (Bio-Rad) using an iTaq Universal SYBR Green Supermix (Bio-Rad) following the instructions of the manufacturer. All samples were run in triplicate, and GAPDH was used as an internal control. The expression level of P2YR mRNA or P2XR mRNA was normalized to GAPDH and is expressed as a ratio relative to GAPDH.
Cell viability assay. Viability of human non-small cell lung cancer cell line A549 and H23 and normal human airway epithelial cell line after treatments with DMEM with 10% FBS, 100 M ATP in DMEM with 10% FBS, and 1 mM ATP DMEM with 10% FBS was determined by the Trypan blue dye exclusion assay. Control and treated cells were incubated with Trypan blue solution for 3-5 min and then counted on Countess (Invitrogen, Grand Island, NY). Cell numbers per milliliter cell suspension were determined in each preparation, and the percentage of cells that excluded Trypan blue stain is indicated as a measure of cell viability, which is expressed in percentage (%).
Statistical analysis. Pooled data are shown as means Ϯ SE. The statistical significance between two groups was determined by Student's t-test. The statistical significance among groups was determined by Scheffé's test after one-way analysis of variance. Significant difference is expressed in the figures or figure legends as P Ͻ 0.05. (Fig. 1D) . Of the responding cells, we observed three patterns: 1) Pattern 1, a transient increase followed by a plateau increase; 2) Pattern 2, a transient increase followed by a slowly declining increase; and 3) Pattern 3, only a transient increase (Fig. 1B) . Pattern 3 represents the highest proportion of normal responding cells (78%) (Fig. 1E) . In contrast, Pattern 1 represents the highest proportion of responding lung cancer cells (H23, 70%; A549, 55%) (Fig. 1E) . Furthermore, we observed that in all cell types the amplitude of the transient increase ( Fig. 2C ) and the amplitude of the plateau increase ( Fig. 2D) to ATP with a transient increase in [Ca 2ϩ ] cyt (Fig. 3, A-C) . In H23 cells, ATP induced a transient increase in [Ca 2ϩ ] cyt in 95% of the cells; however, the plateau phase increase of [Ca 2ϩ ] cyt was no longer observed (Fig. 3, A-C (Fig. 3, A-C) . Extracellular ATP induced transient increases in (Fig. 4B) (19, 44) . Next, we treated cells with cyclopiazonic acid (CPA), a reversible inhibitor of the SR/ER Ca 2ϩ -pump (SERCA), passively depletes Ca 2ϩ from the SR and induces SOCE. We observed that the second increase in [Ca 2ϩ ] cyt due to extracellular Ca 2ϩ restoration-mediated SOCE was significantly lower in H23 cells (0.10 Ϯ 0.004) than in normal cells (0.45 Ϯ 0.022, P Ͻ 0.05); however, we did not observe a significant difference in A549 cells (0.40 Ϯ 0.010) compared with normal cells (Fig. 4, C and G) . When ATP was then introduced to the cells in the presence of extracellular Ca 2ϩ , we observed that the second increase in [Ca 2ϩ ] cyt was significantly higher than that in the presence of extracellular Ca 2ϩ without ATP in both normal and lung cancer cells (0.51 Ϯ 0.010 for normal cells; 0.13 Ϯ 0.003 for H23 cells; 0.47 Ϯ 0.008 for A549 cells; P Ͻ 0.05 vs. the value in the absence of ATP) (Fig. 4, D, F, and G) .
RESULTS
Extracellular
To determine whether P2X receptors are involved, we pre- (Fig. 4, E (20, 21, 39) . The P2X 7 receptor is known to be involved in non-Bcl-2/Baxmediated cell apoptosis (29, 44) . The loss of P2X 7 in lung cancer cells is surprising, given that numerous studies have reported that ATP can exert a cytotoxic effect on several tumor cell types (6, 12, 33, 43) . Therefore, we investigated whether extracellular ATP has a differential effect on cell growth processes (including cell apoptosis and cell proliferation) in normal cells versus lung cancer cells.
There was no effect of 100 M ATP on cell viability in both normal and lung cancer cells in comparison to their control during ATP stimulation at 24, 48, and 72 h, respectively (Fig.  6A) . However, a decrease in cell viability was observed when normal cells were treated with 1 mM ATP for 48 h (75.33% Ϯ 9.23 vs. control of 89.25% Ϯ 3.74, P Ͻ 0.05) and 72 h C104 (73.16% Ϯ 5.23 vs. control of 90.23% Ϯ 3.61, P Ͻ 0.05). Decreased cell viability was also observed in H23 lung cancer cells at 72 h (65.00% Ϯ 6.61 vs. control of 81.00% Ϯ 3.88, P Ͻ 0.05) with 1 mM ATP, while no change of cell viability was observed in A549 lung cancer cells (Fig. 6A) .
We next examined the ability of ATP to affect cell proliferation. Cell proliferation was inhibited in normal cells treated with 100 M ATP for at 72 h (4.25 ϫ 10 6 Ϯ 0.45 vs. control of 7.22 ϫ 10 6 Ϯ 2.00, P Ͻ 0.05) and with 1 mM ATP for 48 h (3.06 ϫ 10 6 Ϯ 0.81 vs. control of 5.69 ϫ 10 6 Ϯ 0.89, P Ͻ 0.05) and 72 h (3.06 ϫ 10 6 Ϯ 1.03 vs. control of 7.22 ϫ 10 6 Ϯ 2.00, P Ͻ 0.05) (Fig. 6B) . There was also a small decrease in cell proliferation in lung cancer cells at 72 h when cells were treated with 100 M ATP (1.03 ϫ 10 6 Ϯ 0.59 vs. control of 1.74 ϫ 10 6 Ϯ 0.50 for H23 cells; 4.08 ϫ 10 6 Ϯ 0.88 vs. control of 5.82 ϫ 10 6 Ϯ 0.97 for A549 cells, P Ͻ 0.05). However, no change in cell proliferation was observed in lung cancer cells when treated with 1 mM ATP (Fig. 6B ). These data indicate that relatively low concentrations of ATP (micromole) negatively modulate cell proliferation but not cell viability in lung cancer cells. Higher concentrations of ATP (in the millimolar range), however, do not affect cell proliferation in lung cancer cells, but induce decreased cell viability in H23 cells. In normal cells, in which P2X 7 receptors are expressed at a higher level, we observed consistent effects of ATP on cell viability and cell proliferation. Future studies are needed to determine whether the absence of P2X 7 uncouples cell viability and proliferation in lung cancer cells.
ATP increases the Bcl-2/Bax ratio in lung cancer cells.
Since the lung cancer cells (H23 and A549) express low levels of the P2X 7 receptor, we considered whether ATP could modulate cell apoptosis by other means. Antiapoptotic Bcl-2 is well known for its classic role in blocking cytochrome c release from mitochondria and thereby inhibiting apoptosis; its expression is upregulated in many tumor cells (9, 10) . Bax, a member of the Bcl-2 family of proteins, has a proapoptotic role that opposes Bcl-2; as such, high Bcl-2/Bax ratio represents an antiapoptotic cell state. Therefore we examined the expression levels of both Bcl-2 and Bax proteins to determine whether extracellular ATP affects Bcl-2/Bax ratio in normal and lung cancer cells.
The cells were first treated with vehicle (water) for 0, 2, 4, 8, 16, and 24 h; Bcl-2 and Bax protein expression levels, as well as Bcl-2/Bax ratio, showed no change in both normal and lung cancer cells (Fig. 7, A, D, and E) . We observed that Bcl-2 protein expression level was higher in basal conditions (0 h) in lung cancer cells than in normal cells, while the Bax protein expression level showed no difference between normal and lung cancer cells (Fig. 7, A and D) . We next treated cells with ATP (100 M and 1 mM) for 0, 2, 4, 8, 16, 24 h. In normal cells, both Bcl-2 and Bax protein expression levels, as well as Bcl-2/Bax ratio, were not changed following treatment with ATP (100 M and 1 mM) (Fig. 7, B, C, F, G, H, and I) . In lung cancer cells (H23 and A549), Bcl-2 protein expression was upregulated following treatment with ATP (100 M and 1 mM) from 2 h to 24 h, while Bax protein level was negligibly changed or slightly (but not significantly) increased (Fig. 7, B,  C, F, and H) . The Bcl-2/Bax ratio was significantly increased following treatment of lung cancer cells (H23 and A549) with ATP (100 M and 1 mM) (Fig. 7, G and I) . We observed that Bcl-2, rather than Bax, was more sensitive to ATP in lung cancer cells H23 and A549. In normal cells, because of the low expression level of Bcl-2 protein, the Bcl-2/Bax ratio was much lower and less affected by ATP than in lung cancer cells. However, consistent with the decreased viability observed in ]cyt before, during, and after application of 100 M UTP (n ϭ 3) (right).
normal cells, Bax protein expression was upregulated in these cells following treatment with ATP. These data suggest that an ATP-induced increase of the Bcl-2/Bax ratio in lung cancer cells may be the mechanism by which lung cancer cells escape from ATP-induced cytotoxic effects.
Intracellular Ca 2ϩ is required for extracellular ATP to increase Bcl-2/Bax ratio in lung cancer cells.
To understand the potential mechanism by which ATP increases Bcl-2/Bax ratio, we focused on ATP-induced [Ca 2ϩ ] cyt increase, which is one of the major downstream messengers of P2 receptor (P2X and P2Y) activation. Cells were treated with BAPTA-AM, a membrane-permeable Ca 2ϩ chelator, for 30 min before treatment with ATP (100 M and 1 mM) to determine whether intracellular Ca 2ϩ is required for regulation of Bcl-2 and Bax protein expression (37) . BAPTA-AM pretreatment blocked the ATP-induced increase of [Ca 2ϩ ] cyt in both normal and lung cancer cells (H23 and A549) (Fig. 8, A and B) . We also treated cells with ATP (100 M and 1 mM) for 0, 2, 4, 8, 16, 24 h, respectively, after BAPTA-AM treatment to determine whether intracellular Ca 2ϩ is required for ATP-induced increase in Bcl-2/Bax ratio. In both normal and lung cancer cells, chelation of intracellular Ca 2ϩ with BAPTA-AM precluded the ATP-induced changes in Bcl-2 and Bax protein expression and Bcl-2/Bax ratio (Fig. 8, C-H (Fig. 9, A and B) . We also treated cells with ATP (100 M and 1 mM) for 0, 2, 4, 8, 16, 24 h in 80 nM Ca 2ϩ media and then measured expression levels of Bcl-2 and Bax proteins. In both normal and lung cancer cells, Bcl-2 and Bax protein expression levels, as well as Bcl-2/Bax ratio, showed no change during ATP treatment (100 M and 1 mM) in the extracellular media containing low (80 nM) Ca 2ϩ concentration (Fig. 9, C-H influx (plateau phase) in both normal and lung cancer cells (Fig. 10, A and B) . When we treated both normal and cancer cells with ATP (100 M and 1 mM) following U-73122 treatment for 0, 2, 4, 8, 16, 24 h, we did not see any changes in the Bcl-2/Bax ratio (Fig. 10, C-H) . Accordingly, blockade of P2Y receptors, which signal through the PLC/IP 3 / DAG signaling cascade to induce Ca 2ϩ release and influx, made it possible to eliminate both the transient and plateau phases of increase in [Ca 2ϩ ] cyt . These data suggest that the P2X receptors (nonselective cation channels) are not the major channels for ATP-induced Ca 2ϩ influx in lung cancer cells. Furthermore, these data also suggest that the Ca 2ϩ -dependent regulation of Bcl-2/Bax ratios is not mediated by Ca 2ϩ influx through P2X receptors. However, U-73122 has been shown to inhibit phospholipase A2 (PLA2) and 5-lipoxygenase as well. To our knowledge, these enzymes are not involved in Bcl-2/Bax protein regulation. Further stud- ies are needed to focus on investigating the channels that mediate ATP-induced Ca 2ϩ influx required for the plateau phase in lung cancer cells.
DISCUSSION
In addition to functioning as a molecular energy source, ATP is also an important extracellular messenger and agonist.
In this study, we have shown that ATP induces different Ca tors and P2Y 1 , P2Y 2 , P2Y 4 and P2Y 6 receptors are expressed more highly in lung cancer cells than in normal cells. Indeed, P2Xs and P2Ys are known to respond to ATP to regulate tumorigenic behaviors including cell proliferation and apoptosis.
The Ca 2ϩ signal is also known to be involved in many cellular processes that promote tumorigenesis (1, 22) . Ca 2ϩ signaling components that determine Ca 2ϩ signaling homeostasis change their expression or function in the occurrence and development of disease (30) . The remodeling of Ca 2ϩ signaling that occurs in cancer cells is achieved through differential expression of specific Ca 2ϩ pumps and channels (30) . Although alternative Ca 2ϩ signaling is not necessary for cancer initiation, the consequence of onset may contribute to tumor progression. Our study showed that ATP induces markedly Ca 2ϩ influx in lung cancer cells but not in normal cells. The most probable candidate channels for Ca 2ϩ influx are P2Xs, because P2Xs per se are Ca 2ϩ -permeable cation channels (31). As discussed earlier, H23 and A549 lung cancer cells had significantly higher levels of P2X 3 , P2X 4 , and P2X 5 expression compared with normal cells. Studies have shown that P2X receptors desensitize ATP fast and mediate short-time inward current (36) , which may underlie the limited Ca 2ϩ influx induced by the activation of P2X receptors shown in P2X inhibitor and agonist data. ATP (by active depletion of Ca 2ϩ from the intracellular stores) and CPA (by passive depletion of Ca 2ϩ from the intracellular stores) both induced SOCE, but ATP/CPAinduced SOCE in cancer cells was not enhanced, but rather reduced, in H23 lung cancer cells. This result was surprising because aggressive cancer cells would be expected to show stronger Ca 2ϩ signaling intensity in consideration of sustained proliferation and migration. Although it has been demonstrated in proliferative pulmonary artery smooth muscle cells that enhanced SOCE promotes cell proliferation and growth, its effect on tumor growth is less clear (38, 46) . Several studies have shown that, in cancer, decreased SERCA2 expression leads to low ER Ca 2ϩ capacity, which then lowers the risk of mitochondrial Ca 2ϩ overload that triggers cell apoptosis (27, 40 Cell viability results showing that lung cancer cells exhibit resistance to the cytotoxicity of high concentration of ATP in comparison to normal cells are consistent with published data that showed low (nearly undetectable) expression levels of P2X 7 R in lung cancer cells (20, 21, 39) . P2X 7 is considered to act as a proapoptotic factor through increasing cytomembrane permeability activated by a high concentration of ATP (9, 29) . However, significantly decreased cell viability was observed in H23 lung cancer cells at late (72 h) culture but not in A549 lung cancer cells. These two lung cancer cell lines chosen in this study reflect the heterogeneity of the human lung cancer progression pathway, involving, for example, the expression of P53, Myc, and Ras. This allows us to speculate that, despite both being lung carcinoma, each has its own particular response to environmental stimuli. We also showed in both normal and lung cancer cells that ATP affected cell proliferation. It is interesting to note that a lower concentration of ATP reduced cell proliferation in both H23 and A549 lung cancer cells, while reduced cell proliferation was not observed with a higher concentration of ATP. These findings are inconsistent with cell viability results that indicated more cell death in a high concentration of ATP while the cells remained healthy in low concentration. These results suggest that ATP-induced cell apoptosis and cell proliferation are through separate pathways, and each sensitizes to a specific concentration range of ATP.
It is worth mentioning here that A549 lung cancer cells have been reported to secrete extracellular matrix components that have ATP binding sites. In our study, A549 lung cancer cells start to respond to ATP at 1 M, which is the same as H23 lung cancer cells. A strong increase in intracellular Ca 2ϩ increase was observed in A549 lung cancer cells after ATP stimulation, and P2X and P2Y receptor inhibitors weakened ATPinduced intracellular Ca 2ϩ increase in A549 lung cancer cells. These observations suggest that although extracellular matrix components secreted by A549 lung cancer cells might bind ATP, the binding ability is not sufficient to eliminate ATP action on P2 receptors. Therefore, the lack of effect of ATP on cell viability of A549 lung cancer cells is not due to competing binding of ATP to extracellular matrix components.
There are data suggesting that very high intracellular Ca 2ϩ levels can promote cell death through necrosis, whereas sustained and lower intracellular Ca 2ϩ increases induced by milder insults promote cell death through apoptosis (8, 24) . In this study, our data showed that ATP induces slow and long term phase of [Ca 2ϩ ] cyt increase in lung cancer cells, but that ATP at both high and relatively lower levels rarely affected cell viability, which indicates cell apoptosis. This leads us to propose that ATP may enhance the ability of antiapoptosis of lung cancer cells in some way to desensitize the cytotoxicity of Ca 2ϩ overload. Thus, we focused on the Bcl-2/Bax ratio, the change of which determines cell fate. Our data showed that ATP promotes antiapoptosis by increasing Bcl-2/Bax ratio in lung cancer cells. It is of great interest that cancer cells respond to extracellular ATP by increasing survival capacities via multiple anti-death pathways that include low P2X 7 expression, high Bcl-2 expression, and an increased Bcl-2/ Bax ratio.
To provide some insight on the mechanism of ATPmodulated Bcl-2/Bax ratio in lung cancer cells, we abolished ATP-induced [Ca 2ϩ ] cyt increase by using BAPTA-AM and eliminated Ca 2ϩ influx through treating cells in low extracellular Ca 2ϩ media, and both ways led to unchanged Bcl-2/Bax ratio in lung cancer cells. Additionally, U-73122 was applied to abolish Ca 2ϩ mobilizing from intracellular Ca 2ϩ stores rather than extracellular Ca 2ϩ influx. However, calcium image data showed that U-73122 also reduced Ca 2ϩ influx significantly. Cells treated with U-73122 showed no change in the ratio of Bcl-2/Bax after ATP treatment. PLC inhibition leads to attenuation or blockade of two other Ca 2ϩ influx pathways, store-operated Ca 2ϩ entry through SOC and receptor-operated Ca 2ϩ entry through ROC, even when P2Y receptors are activated by ATP. The U-73122 data indicate that, although the P2X family is one of the mechanisms that mediated ATP-induced Ca 2ϩ influx, the P2X contribution to ATP-induced total Ca 2ϩ influx is limited or, by itself, is insufficient to affect Bcl-2 expression and the Bcl-2/Bax ratio. These results suggest that a sustained increase in cytosolic Ca 2ϩ due to Ca 2ϩ influx from the extracellular environment is the critical mediator between extracellular ATP and an enhanced Bcl-2/Bax ratio in lung cancer cells. Thus, determining Ca 2ϩ channels and transporters leading to sustained [Ca 2ϩ ] cyt increase in lung cancer cells would provide an important therapeutic target eliminating ATP-mediated increase in the Bcl-2/Bax ratio and, therefore, attenuating the ability of antiapoptosis of lung cancer cells. In this study, we did not determine possible pathways that lead to enhanced Ca 2ϩ influx in lung cancer cells compared with normal cells. Ca 2ϩ influx through P2X channels or SOCE showed no difference between cancer cells and normal cells. Other channels like VDCC and ROCC or Ca 2ϩ extrusion and sequestration mechanisms such as the Ca 2ϩ -Mg 2ϩ -ATPase in the plasma membrane or SERCA on the membrane of SR or ER might be the reasons, which would be of great interest in a future study.
C112
This study has highlighted the role of ATP in the extracellular microenvironment with regard to tumor cell growth in vitro. Enhancing the antiapoptotic ability of ATP may be an important selective pressure promoting oncogene transformation and cancer progression. We have shown for the first time that ATP increases the Bcl-2/Bax ratio through a sustained increase in [Ca 2ϩ ] cyt in lung cancer cells. Additionally, we have demonstrated that Ca 2ϩ from the extracellular environment mediates this ATP-induced increase in Bcl-2/Bax ratio. This study has several implications for lung cancer biology. It suggests that tumor cells may adapt to high ATP in the tumor microenvironment through low P2X 7 receptor expression to escape apoptosis and also turn ATP into a stimulus to inhibit apoptosis. This conversion of harm to benefit is important for the aggressive behavior of tumors. Despite the exogenous application of ATP having antineoplastic action on tumors, as implicated by several studies, because of its cytotoxicity on low-tolerance normal cells, this side effect weakens its therapeutic value. Thus, understanding this ATP-induced antiapoptotic pathway observed in lung cancer cells would be of therapeutic value to facilitate the development of cancer-specific targeted therapies.
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